168 results
8-K
EX-99.1
DRRX
Durect Corp
21 May 24
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
4:35pm
pathways associated with stress responses, cell death and survival, and lipid biosynthesis. This may ultimately lead to improved cell survival, reduced
8-K
EX-99.1
DRRX
Durect Corp
13 May 24
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
4:17pm
, which subsequently modulates expression of genes that are involved in cell signaling pathways associated with stress responses, cell death and survival
8-K
EX-99.1
DRRX
Durect Corp
30 Apr 24
Other Events
2:30pm
death and survival, and lipid biosynthesis. This may ultimately lead to improved cell survival, reduced inflammation, and decreased lipotoxicity
8-K
EX-99.1
1nonux4l
27 Mar 24
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:15pm
8-K
EX-99.1
5de ne2lzpxgymfenpqe
13 Nov 23
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
4:15pm
8-K
EX-99.1
4ip2tz7
7 Nov 23
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial
4:10pm
8-K
EX-99.2
ygro 8zt94spuyid
7 Nov 23
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial
4:10pm
8-K
EX-99.1
kxn nge1k
7 Sep 23
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial
9:02am
8-K
EX-99.1
efw8lbf1z63rc
9 Aug 23
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
4:23pm
424B5
aba0 xysylc
21 Jul 23
Prospectus supplement for primary offering
10:38am
8-K
EX-10.1
7utsnh8
22 Jun 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
rztub
7 Jun 23
DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
9:00am
8-K
EX-99.1
4dl5r mnhc
16 May 23
Regulation FD Disclosure
12:08pm
8-K
EX-99.1
79xj a3y29lrls0
8 May 23
DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update
4:15pm